Literature DB >> 7667817

Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever.

M V Heller1, R F Marta, A Sturk, J I Maiztegui, C E Hack, J W Cate, F C Molinas.   

Abstract

Junin virus, an arenaviridae, is the etiological agent of Argentine hemorrhagic fever. In addition to thrombocytopenia, patients present several alterations in both the blood coagulation and the fibrinolytic system, but diffuse intravascular coagulation could not be demonstrated. To investigate further the activation status of the two systems, levels of thrombin-antithrombin complexes (TAT), prothrombin fragment 1 + 2, protein C, total and free protein S, C4bBP, antithrombin III, t-PA, PAI-1 and D-dimer were measured. Fourteen patients with a confirmed diagnosis of Argentine hemorrhagic fever were included in the study, 2 were severe, 3 moderate and 9 mild clinical cases, but hemorrhages were slight throughout. Blood samples were collected for 6 consecutive days on admission and on remission. At admission TAT and F1 + 2 levels were increased in 13/14 patients, reaching 0.33 nM (0.06-0.87) and 2.16 nM (0.96-6.5), respectively. PC was low in 4 cases, fPS in 6 and tPS in 2, whereas C4bBP and ATIII values were within normal range. t-PA and D-dimer levels were high in 11/14 patients, reaching 20 ng/ml (2.7-106) and 1660 ng/ml (877-3780) respectively, while PAI-1 was considerably increased in the 2 severe cases and normal in the remainder. These results suggest low level though persistent process of blood coagulation and fibrinolysis activation in this viral hemorrhagic disease. We believe these abnormalities may lead to the well described bleeding manifestations in these patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7667817

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  5 in total

1.  Prognostic significance of antithrombin activity in patients with crimean-congo hemorrhagic Fever.

Authors:  Zulal Ozkurt; Kemalettin Ozden; Ilhami Kiki; Mustafa Usanmaz
Journal:  Eurasian J Med       Date:  2011-08

2.  Junín virus infection of human hematopoietic progenitors impairs in vitro proplatelet formation and platelet release via a bystander effect involving type I IFN signaling.

Authors:  Roberto G Pozner; Agustín E Ure; Carolina Jaquenod de Giusti; Lina P D'Atri; Joseph E Italiano; Oscar Torres; Victor Romanowski; Mirta Schattner; Ricardo M Gómez
Journal:  PLoS Pathog       Date:  2010-04-15       Impact factor: 6.823

Review 3.  Pathogenic mechanisms involved in the hematological alterations of arenavirus-induced hemorrhagic fevers.

Authors:  Mirta Schattner; Leonardo Rivadeneyra; Roberto G Pozner; Ricardo M Gómez
Journal:  Viruses       Date:  2013-01-21       Impact factor: 5.048

4.  Evaluation of Prognostic Values of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Crimean-Congo Hemorrhagic Fever Patients.

Authors:  Yunus Gurbuz; Baris Ozturk; Emin Ediz Tutuncu; Irfan Sencan; Gonul Cicek Senturk; Fatma Aybala Altay
Journal:  Jundishapur J Microbiol       Date:  2015-10-20       Impact factor: 0.747

Review 5.  Treatment of Argentine hemorrhagic fever.

Authors:  Delia A Enria; Ana M Briggiler; Zaida Sánchez
Journal:  Antiviral Res       Date:  2007-11-20       Impact factor: 5.970

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.